Log in

NASDAQ:KEQUKewaunee Scientific Stock Price, Forecast & News

$9.70
+0.04 (+0.41 %)
(As of 05/22/2020 04:00 PM ET)
Add
Compare
Today's Range
$9.70
Now: $9.70
$9.70
50-Day Range
$7.07
MA: $9.12
$10.97
52-Week Range
$6.96
Now: $9.70
$22.52
Volume196 shs
Average Volume1,646 shs
Market Capitalization$26.68 million
P/E RatioN/A
Dividend YieldN/A
Beta0.4
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture products. The company operates in two segments, Domestic and International. Its products include steel, wood, laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture; and laminate caseworks that are used in educational, healthcare, and industrial applications. The company sells its products primarily through dealers, commissioned agents, and a national distributor, as well as through competitive bids submitted by the company and its subsidiaries in Singapore, India, and China. Kewaunee Scientific Corporation was founded in 1906 and is headquartered in Statesville, North Carolina.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.8Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.03 out of 5 stars


Industry, Sector and Symbol

Industry Laboratory apparatus & furniture
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNASDAQ:KEQU
CUSIPN/A
Phone704-873-7202

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$146.55 million
Cash Flow$1.81 per share
Book Value$17.37 per share

Profitability

Net Income$1.53 million

Miscellaneous

EmployeesN/A
Market Cap$26.68 million
Next Earnings Date6/16/2020 (Estimated)
OptionableNot Optionable

Receive KEQU News and Ratings via Email

Sign-up to receive the latest news and ratings for KEQU and its competitors with MarketBeat's FREE daily newsletter.

Kewaunee Scientific (NASDAQ:KEQU) Frequently Asked Questions

How has Kewaunee Scientific's stock been impacted by COVID-19 (Coronavirus)?

Kewaunee Scientific's stock was trading at $9.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, KEQU stock has increased by 7.8% and is now trading at $9.70. View which stocks have been most impacted by Coronavirus.

When is Kewaunee Scientific's next earnings date?

Kewaunee Scientific is scheduled to release its next quarterly earnings announcement on Tuesday, June 16th 2020. View our earnings forecast for Kewaunee Scientific.

How were Kewaunee Scientific's earnings last quarter?

Kewaunee Scientific Co. (NASDAQ:KEQU) released its quarterly earnings results on Tuesday, March, 3rd. The technology company reported ($0.70) earnings per share (EPS) for the quarter. The technology company earned $34.23 million during the quarter. Kewaunee Scientific had a negative return on equity of 8.81% and a negative net margin of 3.31%. View Kewaunee Scientific's earnings history.

How often does Kewaunee Scientific pay dividends? What is the dividend yield for Kewaunee Scientific?

Kewaunee Scientific declared a quarterly dividend on Wednesday, August 28th. Shareholders of record on Tuesday, September 10th will be paid a dividend of $0.19 per share on Tuesday, September 24th. This represents a $0.76 annualized dividend and a dividend yield of 7.84%. The ex-dividend date is Monday, September 9th. View Kewaunee Scientific's dividend history.

Has Kewaunee Scientific been receiving favorable news coverage?

News articles about KEQU stock have trended somewhat negative on Sunday, according to InfoTrie Sentiment. The research group rates the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Kewaunee Scientific earned a coverage optimism score of -1.0 on InfoTrie's scale. They also gave news headlines about the technology company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the next several days. View the latest news aboutKewaunee Scientific.

Are investors shorting Kewaunee Scientific?

Kewaunee Scientific saw a increase in short interest in May. As of May 15th, there was short interest totaling 4,500 shares, an increase of 60.7% from the April 30th total of 2,800 shares. Based on an average trading volume of 7,200 shares, the days-to-cover ratio is presently 0.6 days. Currently, 0.2% of the company's shares are short sold. View Kewaunee Scientific's Current Options Chain.

Who are some of Kewaunee Scientific's key competitors?

What other stocks do shareholders of Kewaunee Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Kewaunee Scientific investors own include AT&T (T), Verizon Communications (VZ), AbbVie (ABBV), KEMET (KEM), Magnachip Semiconductor (MX), Canopy Growth (CGC), Alphabet (GOOG), Marathon Petroleum (MPC), Pro-Dex (PDEX) and Amtech Systems (ASYS).

Who are Kewaunee Scientific's key executives?

Kewaunee Scientific's management team includes the following people:
  • Mr. David M. Rausch, CEO, Pres & Director (Age 60)
  • Mr. Thomas D. Hull III, VP of Fin., CFO, Treasurer & Sec. (Age 43)
  • Ms. Elizabeth D. Phillips, VP of HR (Age 42)
  • Mr. Bhoopathy Sathyamurthy, Managing Director of International Operations (Age 50)
  • Mr. Kurt P. Rindoks, VP of Product Devel. & International Sourcing (Age 61)

What is Kewaunee Scientific's stock symbol?

Kewaunee Scientific trades on the NASDAQ under the ticker symbol "KEQU."

Who are Kewaunee Scientific's major shareholders?

Kewaunee Scientific's stock is owned by many different retail and institutional investors. Top institutional shareholders include North Star Investment Management Corp. (3.55%), Minerva Advisors LLC (3.30%), BlackRock Inc. (0.54%) and Wedbush Securities Inc. (0.37%). View institutional ownership trends for Kewaunee Scientific.

Which major investors are selling Kewaunee Scientific stock?

KEQU stock was sold by a variety of institutional investors in the last quarter, including North Star Investment Management Corp.. View insider buying and selling activity for Kewaunee Scientific.

Which major investors are buying Kewaunee Scientific stock?

KEQU stock was bought by a variety of institutional investors in the last quarter, including Minerva Advisors LLC, Wedbush Securities Inc., and BlackRock Inc.. View insider buying and selling activity for Kewaunee Scientific.

How do I buy shares of Kewaunee Scientific?

Shares of KEQU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Kewaunee Scientific's stock price today?

One share of KEQU stock can currently be purchased for approximately $9.70.

How big of a company is Kewaunee Scientific?

Kewaunee Scientific has a market capitalization of $26.68 million and generates $146.55 million in revenue each year.

What is Kewaunee Scientific's official website?

The official website for Kewaunee Scientific is www.kewaunee.com.

How can I contact Kewaunee Scientific?

Kewaunee Scientific's mailing address is 2700 W FRONT ST, STATESVILLE NC, 28677. The technology company can be reached via phone at 704-873-7202 or via email at [email protected]

This page was last updated on 5/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.